文献速递口腔修复与种植牙周病

无翻瓣手术治疗种植体周炎联合表面去污与全身抗生素的回顾性病例系列研究

Treatment of peri-implantitis with a flapless surgical access combined with implant surface decontamination and adjunctive systemic antibiotics: A retrospective case series study.
PubMed 文献 · J Clin Periodontol · 2024-05-01

随访结束时94.9%患者和87.3%种植体无需进一步治疗,牙周炎病史和基线探诊深度为负性预测因素,依从支持性维护、 machined表面及辅助使用阿奇霉素或甲硝唑为正性预测因素。

要点

  • 无翻瓣手术联合去污治疗种植体周炎可使54.4%种植体达到疾病消退。
  • 牙周炎病史和基线探诊深度是疾病消退的负性预测因素。
  • 依从支持性维护、machined表面及辅助使用阿奇霉素或甲硝唑是正性预测因素。

核心结论

  • 无翻瓣手术入路可使54.4%的种植体周炎种植体达到疾病消退。
  • 研究识别了多个影响疾病消退的风险和保护性预测因素。

研究设计与样本

  • 回顾性研究评估至少一枚种植体诊断为种植体周炎并接受无翻瓣手术入路治疗的患者,伴或不伴全身抗菌药物、刮治及必要时修复体修改。

主要发现

  • 疾病消退定义为≤1个出血位点、探诊深度≤5 mm、无骨丧失>0.5 mm,在338枚种植体中54.4%达到该终点。
  • 随访结束时111例患者(94.9%)的295枚种植体(87.3%)无需进一步治疗,其中81.4%的种植体探诊深度≤5 mm。
  • 牙周炎病史和基线探诊深度被确定为疾病消退的负性预测因素。
  • 依从支持性种植体周维护、machined表面以及辅助使用全身阿奇霉素或甲硝唑被确定为疾病消退的正性预测因素。

关键数值与推荐

  • 疾病消退标准:≤1个出血位点、探诊深度≤5 mm、无骨丧失>0.5 mm。

临床怎么用

  • 无翻瓣手术入路可作为种植体周炎的治疗选择之一,尤其适用于特定预测因素有利的患者。
  • 临床应关注患者的牙周炎病史和基线探诊深度,并鼓励依从支持性维护。
  • 辅助使用阿奇霉素或甲硝唑可能提高疾病消退概率,但需结合患者具体情况。

局限性

  • 回顾性研究设计可能存在选择偏倚和信息偏倚。
  • 无对照组,无法直接比较无翻瓣手术与其他治疗方式的疗效差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To evaluate the effectiveness of a flapless surgical approach in the treatment of peri-implantitis and to explore the factors influencing its outcome. MATERIALS AND METHODS: The present retrospective study evaluated patients with at least one implant diagnosed with peri-implantitis and treated with a flapless surgical access, with or without systemic antimicrobials, curettage and, when needed, prostheses modification. Clinical and radiographic parameters were assessed at baseline and at 3 months and at least 12 months. The primary outcome was disease resolution (≤1 bleeding sites, probing depth [PD] ≤5 mm, no bone loss >0.5 mm). Multilevel regression analyses were used to identify predictors influencing the probability of attaining disease resolution. RESULTS: One hundred and seventeen patients with 338 implants were included. Disease resolution was attained in 54.4% of the 338 implants receiving flapless surgical access. At the end of the follow-up period, 111 patients (94.9%) with 295 implants (87.3%) did not require any further treatment, with 81.4% of these implants presenting PD ≤ 5 mm. History of periodontitis and PD at baseline were identified as negative predictors, while compliance with supportive peri-implant care, a machined surface and the adjunctive use of systemic azithromycin or metronidazole were identified as positive predictive factors for disease resolution. CONCLUSIONS: A flapless surgical approach led to disease resolution in 54.4% of the implants with peri-implantitis. Several risk/protective predictors for disease resolution were identified.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Carrillo de Albornoz A, Montero E, Alonso-Español A, et al. Treatment of peri-implantitis with a flapless surgical access combined with implant surface decontamination and adjunctive systemic antibiotics: A retrospective case series study. J Clin Periodontol. 2024. PMID: 38690660. doi:10.1111/jcpe.13993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。